- Trials with a EudraCT protocol (18)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
18 result(s) found for: Chlamydia infection.
Displaying page 1 of 1.
EudraCT Number: 2013-002379-17 | Sponsor Protocol Number: 2013-CT-ME | Start Date*: 2013-12-06 | ||||||||||||||||||||||||||
Sponsor Name:Oslo University Hospital healt Trust [...] | ||||||||||||||||||||||||||||
Full Title: MECILLINAM FOR TREATMENT OF GENITAL CHLAMYDIA INFECTION IN ASYMPTOMATIC MEN. | ||||||||||||||||||||||||||||
Medical condition: Asymptomatic genital Chlamydia Trachomatis infection | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||||||||||||
Trial protocol: NO (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002829-29 | Sponsor Protocol Number: ANRS174 | Start Date*: 2019-12-12 |
Sponsor Name:INSERM ANRS | ||
Full Title: Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex with Men using oral TDF/FTC for HIV Pre-Exposure Prophylaxis (PrEP) | ||
Medical condition: MSM with at least 6-month experience with PrEP (Pre-Exposure Prophylaxis) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005795-41 | Sponsor Protocol Number: IELSG27 | Start Date*: 2006-09-12 | |||||||||||
Sponsor Name:INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG) | |||||||||||||
Full Title: A CLINICO-PATHOLOGICAL PHASE II STUDY WITH TRANSLATIONAL ELEMENTS TO INVESTIGATE THE POSSIBLE INFECTIVE CAUSES OF NON-HODGKIN LYMPHOMA OF THE OCULAR ADNEXAE WITH PARTICULAR REFERENCE TO CHLAMYDIA ... | |||||||||||||
Medical condition: MALT lymphoma of the ocular adnexae | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002569-32 | Sponsor Protocol Number: izoz/0025 | Start Date*: 2015-06-12 |
Sponsor Name:Academic Medical Center | ||
Full Title: Biomedical interventions for HIV prevention in MSM in Amsterdam: a demonstration project | ||
Medical condition: prevention of HIV infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-006277-92 | Sponsor Protocol Number: AIN2008 | Start Date*: 2009-06-23 | |||||||||||
Sponsor Name:Academic Medical Center, department of infectious diseases | |||||||||||||
Full Title: Treatment of anal intraepithelial neoplasia in HIV-positive patients, a triple-arm randomized clinical trial | |||||||||||||
Medical condition: anal intraepithealial neoplasia in HIV-positive patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003447-21 | Sponsor Protocol Number: MMC001 | Start Date*: 2011-12-15 | |||||||||||
Sponsor Name:Camden Provider Services | |||||||||||||
Full Title: Randomised controlled trial of the tolerability and completion of maraviroc compared to Kaletra© in combination with Truvada© for HIV post-exposure prophylaxis | |||||||||||||
Medical condition: Prophylaxis and prevention of HIV Infection. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-005078-37 | Sponsor Protocol Number: SOPHOCLES-P4G | Start Date*: 2017-05-26 | |||||||||||
Sponsor Name:Hellenic Scientific Society for the Study of AIDS and Sexually Transmitted Diseases | |||||||||||||
Full Title: Public health targeting of PrEP at HIV positives’ bridging networks | |||||||||||||
Medical condition: Healthy volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003666-13 | Sponsor Protocol Number: VAC89220HPX3002 | Start Date*: 2019-10-15 | |||||||||||
Sponsor Name:Janssen Vaccines & Prevention B.V. | |||||||||||||
Full Title: A Multi-center, Randomized, Double-blind, Placebo-controlled Phase 3 Efficacy Study of a Heterologous Vaccine Regimen of Ad26.Mos4.HIV and Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1... | |||||||||||||
Medical condition: Prevention of HIV-1 Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Restarted) PL (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004192-12 | Sponsor Protocol Number: NL66079.029.18 | Start Date*: 2019-08-05 |
Sponsor Name:Amsterdam UMC, location VU medical Center | ||
Full Title: Oil- based versus water-based contrast media for hysterosalpingography (HSG) in infertile women with unevaluated indications: a randomized controlled trial | ||
Medical condition: The research population consists of infertile couples who have tried to conceive for at least 12 months, or have oligo- or anovulation. We will focus on women with ovulation disorders, or at high r... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003309-79 | Sponsor Protocol Number: MK-8591-024 | Start Date*: 2021-04-30 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Preexposure Prophylaxis in Cisgender Men and Transgender... | |||||||||||||
Medical condition: HIV Preexposure prophylaxis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002867-13 | Sponsor Protocol Number: POP6135,HMR3647B/3005 | Start Date*: 2015-03-17 | |||||||||||
Sponsor Name:Sanofi-aventis | |||||||||||||
Full Title: Multinational, randomized, double blind, double dummy, pharmacokinetic study of telithromycin oral suspension (25 mg/kg once daily for 7-10 days), with secondary assessments of safety relative to a... | |||||||||||||
Medical condition: Community acquired pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002373-56 | Sponsor Protocol Number: | Start Date*: 2012-10-02 | |||||||||||
Sponsor Name:Medical Research Council | |||||||||||||
Full Title: PRe-exposure Option for reducing HIV in the UK: an open-label randomisation to immediate or Deferred daily Truvada for HIV negative gay men | |||||||||||||
Medical condition: HIV infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004952-80 | Sponsor Protocol Number: A0661158 | Start Date*: 2015-04-03 | |||||||||||
Sponsor Name:Pfizer Inc | |||||||||||||
Full Title: Phase 3, Open-Label, Randomized, Comparative Study to Evaluate Azithromycin plus Chloroquine and Sulfadoxine plus Pyrimethamine Combinations for Intermittent Preventive Treatment of Falciparum Mala... | |||||||||||||
Medical condition: Intermittent Preventive Treatment In Pregnancy (IPTp) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001399-31 | Sponsor Protocol Number: GS-US-412-2055 | Start Date*: 2016-12-13 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Me... | |||||||||||||
Medical condition: Healthy volunteers (Pre-exposure prophylaxis (PrEP) of human immunodeficiency virus 1 (HIV-1)) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Ongoing) IE (Trial now transitioned) AT (Trial now transitioned) DK (Trial now transitioned) NL (Completed) ES (Ongoing) FR (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023254-36 | Sponsor Protocol Number: GUMPID002 | Start Date*: 2011-06-22 | |||||||||||
Sponsor Name:Brighton and Sussex University Hospitals NHS Trust | |||||||||||||
Full Title: Is a short course of azithromycin effective in the treatment of mild to moderate pelvic inflammatory disease (PID)? | |||||||||||||
Medical condition: Pelvic Inflammatory Disease (PID) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002819-25 | Sponsor Protocol Number: GU18/108645 | Start Date*: 2020-04-22 | |||||||||||
Sponsor Name:Leeds Teaching Hospital NHS Trust | |||||||||||||
Full Title: Dequalinium versus usual care antibiotics for the treatment of bacterial vaginosis (DEVA): a multicentre, randomised, open label, non-inferiority trial | |||||||||||||
Medical condition: Bacterial vaginosis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003893-46 | Sponsor Protocol Number: NA | Start Date*: 2009-11-03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:KULeuven and University Hospitals Leuven (Leuven Lung Transplant Group) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: AZITHROMYCIN IN BRONCHIOLITIS OBLITERANS SYNDROME | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: - Chronic rejection at 1 and 2 year post-lung transplantation - Mortality at 1 and 2 year post-lung transplantation - Acute rejection rate at 1 and 2 post-lung transplantation - Infection rate at 1... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: BE (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-001546-25 | Sponsor Protocol Number: NL48960.029.14 | Start Date*: 2015-01-06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:VU University Medical Center | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Short versus extended antibiotic treatment with a carbapenem for high-risk febrile neutropenia in hematology patients with Fever of Unknown Origin: a randomized multicenter open-label non-inferiori... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Febrile neutropenia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
